Douglas C. Stahl, Ph.D., M.B.A As vice president of clinical research

Douglas C. Stahl, Ph.D., M.B.A
As vice president of clinical research operations, Dr. Douglas C. Stahl
provides leadership and oversight for City of Hope’s clinical and
translational research programs, including regulatory compliance,
quality assurance, and clinical trial finance.
City of Hope—a not-for-profit clinical research center, hospital, and
graduate medical school—is recognized worldwide for its
compassionate patient care, innovative science, and translational
research which rapidly turns laboratory breakthroughs into promising
new therapies. One of only 40 National Cancer Institute-designated
Comprehensive Cancer Centers nationwide and a founding member of
the National Comprehensive Cancer Network, City of Hope is a leader in the fight to conquer
cancer, diabetes, HIV/AIDS, and other life-threatening diseases.
Prior to joining City of Hope, Stahl was a certified pulmonary technologist and software
development consultant for Sun Health Corporation in Arizona. He joined City of Hope in 1989
as a research engineer in the Department of Immunology and was appointed to direct the newly
formed Division of Biomedical Informatics in 1998. Over the next decade, he created an
interdisciplinary informatics program that continues to develop a broad range of innovative
solutions for research information management. Under Stahl’s leadership, the cancer center’s
Biomedical Informatics Core has become one of its most widely used and highly rated shared
resource facilities.
Stahl holds an undergraduate degree in biomedical engineering from Arizona State University, a
master’s and doctoral degree in information science from Claremont Graduate University’s
(CGU) School of Information Systems and Technology, and an executive MBA from CGU’s
Peter Drucker and Masatoshi Ito School of Management. He also holds a certificate in Lean and
Six Sigma process improvement from Villanova University.
In addition to authoring numerous peer-reviewed publications and conference presentations,
Stahl is a member of the American Society for Quality and the American Medical Informatics
Association. He currently serves on the national steering committee for the Association of
American Cancer Institutes’ Clinical Research Initiative.